These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 26041981)
21. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Terwel D; Dewachter I; Van Leuven F Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809 [TBL] [Abstract][Full Text] [Related]
22. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434 [TBL] [Abstract][Full Text] [Related]
23. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268 [TBL] [Abstract][Full Text] [Related]
24. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
25. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Sambamurti K; Greig NH; Lahiri DK Neuromolecular Med; 2002; 1(1):1-31. PubMed ID: 12025813 [TBL] [Abstract][Full Text] [Related]
26. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. Heininger K Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271 [TBL] [Abstract][Full Text] [Related]
27. [Alzheimer's disease and diabetes - the common pathogenesis]. Halmos T; Suba I Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867 [TBL] [Abstract][Full Text] [Related]
28. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model. Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083 [TBL] [Abstract][Full Text] [Related]
29. Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease. Harris SA; Harris EA Front Aging Neurosci; 2018; 10():48. PubMed ID: 29559905 [TBL] [Abstract][Full Text] [Related]
31. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks. Castrillo JI; Oliver SG Methods Mol Biol; 2016; 1303():3-48. PubMed ID: 26235058 [TBL] [Abstract][Full Text] [Related]
32. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers. Nasoohi S; Parveen K; Ishrat T J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683 [TBL] [Abstract][Full Text] [Related]
33. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1. Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443 [TBL] [Abstract][Full Text] [Related]
34. Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation. van der Harg JM; Eggels L; Ruigrok SR; Hoozemans JJ; la Fleur SE; Scheper W Front Neurosci; 2015; 9():432. PubMed ID: 26617484 [TBL] [Abstract][Full Text] [Related]
35. Metabolic processing of the amyloid precursor protein -- new pieces of the Alzheimer's puzzle. Norstrom E Discov Med; 2017 Apr; 23(127):269-276. PubMed ID: 28595039 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of amyloid deposition in Alzheimer's disease. Beyreuther K; Bush AI; Dyrks T; Hilbich C; König G; Mönning U; Multhaup G; Prior R; Rumble B; Schubert W Ann N Y Acad Sci; 1991; 640():129-39. PubMed ID: 1776729 [TBL] [Abstract][Full Text] [Related]
37. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]